EXHIBIT 10.1
Published on August 27, 2008
Exhibit
10.1
R
E X A H N P H A R M A C E U T I C A L
S, I N C.
9620 Medical
Center Drive, Rockville, MD 20850
Tel.
240-268-5300 Fax.
240-268-5310 www.rexahn.com
August
12, 2008
Ms.
Michele Kang
CEO
Cognosante,
Inc.
7921
Jones Branch Drive, Suite 106
McLean,
Virginia 22102-3332
Re: Consulting
Agreement
Dear
Michele:
This Letter Agreement (the “Agreement”)
sets forth the terms and conditions of the engagement of you by Rexhan
Pharmaceuticals, Inc. (the "Company") to provide certain consulting service to
the Company (the “Service”).
As you are aware, the Company is in the
phase of rapid growth and transformation. In particular, the Company
will be challenged as it pursues corporate growth, possible acquisition,
combination, hiring of executive teams, and other general business
matters. The Service that we hope to obtain from you includes general
business consulting in regard to these matters and other matters as may be
reasonably requested by myself and Ted Jeong.
As discussed, you will be expected to
personally spend eight hours (one working day) per week in providing the Company
with the Service. We do not necessarily expect you to be physically
available at our Company premises in Rockville, Maryland while providing the
Service on the clinical trials on Serdaxin and several types of financial
transactions, but would require your presence when reasonably asked by me or
Ted, or by a director of the Company's board of directors.
The Service to be rendered by you shall
always be in accordance with the professional standard of care commensurate with
similarly situated firms in the Washington, DC Metropolitan area, and you agree
that you shall perform your obligations hereunder in compliance with all
laws.
We expect the Service to be provided
for at least a period of one year from the above date; provided, however, that
the Service can be terminated by either party upon at least thirty (30) days’
prior written notice of its intention to terminate this
Agreement.
Under this Agreement, you shall be an
independent contractor, and not that of principal and agent, employer and
employee, partnership, or affiliate and this Agreement confers no power upon you
to legally to bind or commit the Company, its affiliates or
others. You shall be responsible for the payment of all federal,
state and other taxes with respect to all payments made to you.
As
consideration for the Service, subject to a three (3) year vesting period with
30% of the shares shall vest on the first (1st) anniversary of the grant date;
30% on the second (2nd) anniversary of the grant date; and 40% on the third
(3rd) anniversary of the grant date, you shall be eligible to receive awards of
options to purchase 150,000 shares of the Company's stock (the "Stock Options")
in accordance with the terms of the Company's Stock Option Plan (the "Plan"), as
the Plan may be amended, suspended, or terminated from time to time, and
pursuant to the attached stock option agreement (Attachment A). In
the event that your Service is terminated before the one year term, the award of
Stock Options shall be pro-rated.
In addition to Stock Options, the
Company agrees that it will be solely responsible, and will reimburse you, for
all out-of pocket costs and expenses incurred on behalf of the Company in
connection with the engagement hereunder as evidenced by receipts
hereunder.
This
Agreement shall be governed by the laws of the State of Maryland without regard
to principles of conflicts of laws, and shall not be modified in any way, unless
pursuant to a written agreement which has been executed by each of the parties
hereto. In the event that a dispute shall arise between the parties
to this Agreement concerning any provision of this Agreement (including a
claimed breach hereof), the parties shall first attempt to resolve such dispute
in good faith for at least 20 days. The parties hereby irrevocably
and unconditionally consent to submit to the exclusive jurisdiction of the
courts of the State of Maryland for any lawsuits, claims or other proceedings
arising out of or relating to this Agreement and agree not to commence any such
lawsuit, claim or other proceeding except in such courts.
Please confirm that the foregoing is in
accordance with your understanding by signing and returning to us the enclosed
duplicate of this letter.
Sincerely
yours,
|
||
By:
|
/s/ Chang H. Ahn
|
|
Chang
H. Ahn, Ph.D.
|
||
Chairman/Chief
Executive Officer
|
||
Rexahn
Pharmaceuticals, Inc.
|
Received
and Agreed to:
Cognosante,
Inc.
By:
|
/s/ Michele Kang
|
|
Michele
Kang
|
||
Chief
Executive Officer
|